Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00385021 · ClinicalTrials.gov registry record · Phase 2
ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer
A Phase 2 study, sponsored by Southwestern Regional Medical Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT00385021 is a Phase 2 study that was terminated before completion, run by Southwestern Regional Medical Center. The registered enrollment target is 20 participants.
The verdict
NCT00385021, a Phase 2 study, was terminated before completion, sponsored by Southwestern Regional Medical Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
To determine efficacy in the delivery of chronomodulated chemotherapy.
Interventions
- DRUG 5-Fluorouracil, leucovorin, oxaliplatin, avastin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2006-10 |
| Est. Completion | 2007-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00385021
The ClinicalTrials.gov registry entry for NCT00385021 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Southwestern Regional Medical Center, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 5-Fluorouracil, leucovorin, oxaliplatin, avastin is the first listed.
NCT00385021 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00385021 about?
NCT00385021 is a clinical study titled "ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer". To determine efficacy in the delivery of chronomodulated chemotherapy.
What is the current status of trial NCT00385021?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2006-10. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00385021?
The interventions under investigation include: 5-Fluorouracil, leucovorin, oxaliplatin, avastin (DRUG).
Who is sponsoring clinical trial NCT00385021?
This trial is sponsored by Southwestern Regional Medical Center, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.